These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16447135)

  • 61. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The fragility of the U.S. vaccine supply.
    Sloan FA; Berman S; Rosenbaum S; Chalk RA; Giffin RB
    N Engl J Med; 2004 Dec; 351(23):2443-7. PubMed ID: 15575064
    [No Abstract]   [Full Text] [Related]  

  • 63. Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(39):1079-80. PubMed ID: 18830213
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
    Smith PJ; Kennedy AM; Wooten K; Gust DA; Pickering LK
    Pediatrics; 2006 Nov; 118(5):e1287-92. PubMed ID: 17079529
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vaccine adverse events in the new millennium: is the sky really falling?
    Hinman AR
    Bull World Health Organ; 2000; 78(2):221-2. PubMed ID: 10743291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United States.
    Dennehy PH; Bertrand HR; Silas PE; Damaso S; Friedland LR; Abu-Elyazeed R
    Pediatrics; 2008 Nov; 122(5):e1062-6. PubMed ID: 18977955
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An experiment in Tort reform.
    Flamberg G
    Public Health Rep; 1995; 110(5):635-8. PubMed ID: 7480621
    [No Abstract]   [Full Text] [Related]  

  • 69. National Vaccine Injury Compensation Program: revisions to the vaccine injury table. Final rule.
    Health Resources and Services Administration (HRSA), HHS
    Fed Regist; 2011 Jun; 76(120):36367-9. PubMed ID: 21696014
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New, and some not-so-new, vaccines for adolescents and diseases they prevent.
    Fishbein DB; Broder KR; Markowitz L; Messonnier N
    Pediatrics; 2008 Jan; 121 Suppl 1():S5-14. PubMed ID: 18174321
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
    Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tort reform. Where's the balance?
    Guglielmo WJ
    Med Econ; 2007 Jan; 84(2):70-3. PubMed ID: 17319643
    [No Abstract]   [Full Text] [Related]  

  • 73. [The National Vaccine Injury Compensation Program in Japan].
    Ihara T
    Nihon Rinsho; 2011 Sep; 69(9):1645-50. PubMed ID: 21922768
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunization update: pertussis, meningoccocus, and human papillomavirus.
    Middleman AB
    Adolesc Med Clin; 2006 Oct; 17(3):547-63; abstract ix-x. PubMed ID: 17030279
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Availability of litigation as a public health tool for firearm injury prevention: comparison of guns, vaccines, and motor vehicles.
    Vernick JS; Rutkow L; Salmon DA
    Am J Public Health; 2007 Nov; 97(11):1991-7. PubMed ID: 17901450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Compensation for vaccine-related injuries. Health and Public Policy Committee, American College of Physicians.
    Ann Intern Med; 1984 Oct; 101(4):559-61. PubMed ID: 6476641
    [No Abstract]   [Full Text] [Related]  

  • 77. The case for a vaccine injury compensation program for Canada.
    Wilson K; Keelan J
    Can J Public Health; 2012; 103(2):122-4. PubMed ID: 22530534
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vaccine schedules and procedures, 2007.
    Middleton DB; Zimmerman RK; Mitchell KB
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S47-60, C4-8. PubMed ID: 17270110
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The preteen visit: an opportunity for prevention.
    Campos-Outcalt D
    J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Contingent fees in mass tort litigation.
    Task Force on Contingent Fees of the American Bar Association's Tort Trial & Insurance Practice Section
    Tort Trial Insur Pract Law J; 2006; 42(1):105-31. PubMed ID: 17486724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.